Kenolisa C. Onwueme
Expertise in
43
conditions

Dr. Kenolisa C. Onwueme

Gastroenterology | Hospital Medicine
219 South Washington Street, 
Easton, MD 
Accepting New Patients
Referral may be required
Before you request
Expertise in
43
conditions
219 South Washington Street, 
Easton, MD 

Overview

Dr. Onwueme graduated with Distinction from Yale University with dual BSc/MSc degrees in chemistry and received MD and PhD degrees from Weill Cornell Medical College. He completed his Internal Medicine residency at Brigham and Women’s Hospital (Clinical Fellow Harvard Medical School) and his Gastroenterology fellowship at Johns Hopkins University School of Medicine. He is currently the Director of clinical trials at Woodholme Gastroenterology and has an ardent interest in the role of microbial metabolites in gut diseases. Dr. Onwueme prizes commitment to quality and compassionate patient care to which he devotes his practice. He has expert knowledge in gut microbiology and a special interest in diarrheal diseases, disordered gut motility, autoimmune and inflammatory bowel disease.

Dr. Onwueme is highly rated in 43 conditions, according to our data. His clinical expertise encompasses Gastric Dysmotility, Diverticular Disease, Diarrhea, Endoscopy, and Gastrectomy.

Dr. Onwueme is board certified in American Board Of Internal Medicine and ABIM - Gastroenterology - Gastroenterology, 2012. He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 5 clinical trials. Dr. Onwueme is currently accepting new patients.

Specialties

Gastroenterology
Hospital Medicine

Licenses

Internal Medicine in MA

Board Certifications

American Board Of Internal Medicine
ABIM - Gastroenterology - Gastroenterology, 2012

Fellowships

Johns Hopkins Hospital - Gastroenterology, 2012

Hospital Affiliations

UM Shore Regional Health - Dorchester/Easton
UM Baltimore Washington Medical Center
University Of MD Baltimore Washington Medical Center
The Johns Hopkins Hospital
Johns Hopkins Howard County Medical Center

Languages Spoken

English
Igbo
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

UM Shore Medical Center at Easton
219 South Washington Street, Easton, MD 21601

Additional Areas of Focus

Dr. Onwueme has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
Enrollment Status: Active_not_recruiting
Publish Date: August 11, 2026
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
Enrollment Status: Completed
Publish Date: May 13, 2026
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
View 3 Less Clinical Trials

1 Total Publications

The mycobacterial acyltransferase PapA5 is required for biosynthesis of cell wall-associated phenolic glycolipids.
The mycobacterial acyltransferase PapA5 is required for biosynthesis of cell wall-associated phenolic glycolipids.
Journal: Microbiology (Reading, England)
Published: February 25, 2012
Similar Doctors
Expertise in
13
conditions
Dr. Andrew G. Canakis
Gastroenterology
Expertise in
13
conditions
Dr. Andrew G. Canakis
Gastroenterology
Referral may be required

UM Shore Medical Center At Easton

219 South Washington Street, 
Easton, MD 
 (0.1 miles away)
410-822-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Andrew Canakis is a Gastroenterologist practicing medicine in Easton, Maryland. Dr. Canakis is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Achalasia, Hereditary Pancreatitis, Viral Gastroenteritis, Endoscopy, and Stent Placement. Dr. Canakis is board certified in American Board Of Internal Medicine - Internal Medicine, 2021 and American Board Of Internal Medicine - Gastroenterology, 2024. Dr. Canakis is currently accepting new patients.

Expertise in
12
conditions
Dr. Michael V. Chiorean
Gastroenterology
Expertise in
12
conditions
Dr. Michael V. Chiorean
Gastroenterology
Referral may be required

Swedish Gastroenterology-Issaquah

751 NE Blakely Dr Ste 3020, 
Issaquah, WA 
 (55.8 miles away)
425-313-5345
Languages Spoken:
English, French, Italian, Romanian, Tamil
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Chiorean is a Gastroenterologist practicing medicine in Issaquah, Washington. Dr. Chiorean is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Ulcerative Colitis, Hemorrhagic Proctocolitis, Crohn's Disease, Endoscopy, and Colonoscopy. Dr. Chiorean is currently accepting new patients.

Expertise in
18
conditions
Dr. Joanna K. Law
Gastroenterology
Expertise in
18
conditions
Dr. Joanna K. Law
Gastroenterology
Referral may be required

Confluence Health Hospital-Mares Campus

820 N Chelan Ave, 
Wenatchee, WA 
 (33.7 miles away)
509-663-8711
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Joanna Law is a Gastroenterologist practicing medicine in Wenatchee, Washington. Dr. Law is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Acute Pancreatitis, Hereditary Pancreatitis, Bile Duct Obstruction, Endoscopy, and Colonoscopy. Dr. Law is currently accepting new patients.

Frequently Asked Questions about Dr. Kenolisa C. Onwueme

How do I make an appointment with Dr. Kenolisa C. Onwueme?

You can book an appointment with Dr. Kenolisa C. Onwueme by calling their office at 410-822-1000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Kenolisa C. Onwueme a top-rated expert for Gastric Dysmotility?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kenolisa C. Onwueme is classified as an Advanced expert for Gastric Dysmotility, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Kenolisa C. Onwueme specialize in?

While Dr. Kenolisa C. Onwueme is a Gastroenterology, they have specific expertise in Gastric Dysmotility, Diverticular Disease, and Diarrhea. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Kenolisa C. Onwueme participate in research or clinical trials?

Yes. Dr. Kenolisa C. Onwueme has published 1 articles and abstracts on conditions like Gastric Dysmotility. You can view a list of Dr. Kenolisa C. Onwueme's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Kenolisa C. Onwueme accept my insurance?

Dr. Kenolisa C. Onwueme accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 410-822-1000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Onwueme's expertise for a condition
ConditionClose
      View All 43 Advanced Conditions
      View All 64 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile